BioPharma
BD and Mitsubishi Gas Chemical Have Signed a Letter Of Intent (LOI) to Discuss a Partnership Agreement to Explore New Ways to Advance Biologic Drug Delivery
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. ...
May 18, 2022 | News
Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines
The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...
May 13, 2022 | News
Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...
May 11, 2022 | News
TIKOMED and IQVIA announce a strategic collaboration
Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead ...
May 06, 2022 | News
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
The new Hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early ...
May 05, 2022 | News
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered...
May 04, 2022 | News
Inmagene Receives FDA's IND Clearance for OX40 Antagonist
IMG-007 is highly potent at blocking the binding of OX40 to OX40L, thereby reducing OX40L-dependent downstream signaling and cytokine release by T cells. I...
May 03, 2022 | News
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the FDA for an EV...
April 28, 2022 | News
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
PMC-403 can stabilize and repair damaged and pathologically leaky blood vessels, and it is being developed to treat AMD (Age-related Macular Degeneration),...
April 27, 2022 | News
Biopharmaceuticals: Faster to Market
To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...
April 21, 2022 | Opinion
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...
April 14, 2022 | News
Cambrex Completes Large-Scale US API Expansion
The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex's fl...
April 13, 2022 | News
Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative
Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...
April 12, 2022 | News
CR Pharma intends to make strategic equity investment for Everest's mRNA technology platform
Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...
April 07, 2022 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
